Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $28.8 Million - $43.4 Million
-128,085 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$277.25 - $366.29 $374,842 - $495,224
-1,352 Reduced 1.04%
128,085 $42.4 Million
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $404,347 - $499,465
-1,345 Reduced 1.03%
129,437 $46.5 Million
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $235,434 - $285,535
-759 Reduced 0.58%
130,782 $42.6 Million
Q2 2021

Aug 16, 2021

SELL
$262.71 - $351.17 $84,592 - $113,076
-322 Reduced 0.24%
131,541 $41.1 Million
Q1 2021

May 17, 2021

SELL
$285.92 - $355.13 $16.9 Million - $21 Million
-59,132 Reduced 30.96%
131,863 $42 Million
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $3.85 Million - $4.96 Million
15,302 Added 8.71%
190,995 $61.9 Million
Q3 2020

Nov 16, 2020

SELL
$255.22 - $317.0 $37.9 Million - $47 Million
-148,358 Reduced 45.78%
175,693 $48.7 Million
Q2 2020

Aug 14, 2020

BUY
$141.4 - $257.09 $3.98 Million - $7.23 Million
28,138 Added 9.51%
324,051 $78.3 Million
Q1 2020

May 15, 2020

BUY
$130.51 - $196.01 $1 Million - $1.5 Million
7,677 Added 2.66%
295,913 $43 Million
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $11.3 Million - $15.9 Million
71,054 Added 32.72%
288,236 $49.2 Million
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $38.2 Million - $60.6 Million
217,182 New
217,182 $38.6 Million
Q2 2018

Aug 14, 2018

SELL
$278.07 - $446.21 $34.8 Million - $55.8 Million
-125,007 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$192.49 - $295.85 $7.65 Million - $11.8 Million
-39,753 Reduced 24.13%
125,007 $36.4 Million
Q4 2017

Feb 14, 2018

SELL
$168.78 - $199.74 $7.05 Million - $8.34 Million
-41,768 Reduced 20.22%
164,760 $30.9 Million
Q3 2017

Nov 14, 2017

BUY
$145.39 - $168.6 $30 Million - $34.8 Million
206,528
206,528 $34.8 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.